Report Overview

The South Korea gastro oesophageal reflux disease (GERD) market size stood at around USD 234.6 million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of around xx% during the forecast period.

Gastroesophageal reflux disease (GERD) is a digestive disorder, caused when stomach acid, food, and fluids reflux to the oesophagus. This causes irritation of the lining of oesophagus, resulting in burning sensation. GERD is characterized by two cardinal oesophageal symptoms, including heartburn (reflux) and regurgitation. If left untreated for a prolonged period, it can cause inflammation of oesophagus termed as oesophagitis. Just a few years ago, 'Gastro oesophageal Reflux Disease', that was rare in Korea and was seen only in Westerners, is rapidly emerging as a representative life-related disease in Eastern countries including Korea. Gastroesophageal reflux disease, which affects 1 in 10 people, is also called national disease of Koreans.



Market Drivers

The prevalence rate of GERD is growing rapidly which is the major factor responsible for growth of this market. In geriatric population, acidic complications are recurrent and South Korea is soon going to become a super aged community which will again fuel the growth of market. In addition, advances in the treatment rate and adoption of sedentary lifestyle and research and development activities conducted by many pharmaceutical companies are some of the other propelling factors for the demand of GERD drugs.